Author

Guangbi Yao

Observed names: Guang-Bi Yao, Guang-bi Yao, GuangBi Yao, Guang‐Bi Yao

Observed institution: Changhai Hospital

OpenAlex ID: A5103656906

Long-term safety of lamivudine treatment in patients with chronic hepatitis B

2003 · Anna S.F Lok, Ching-Lung Lai, et al. · Gastroenterology · 760

PDF

Hepatitis B Virus Genotype Distribution among Chronic Hepatitis B Virus Carriers in Shanghai, China

2001 · Xin Ding, Masashi Mizokami, et al. · Intervirology · 173

A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B

2006 · MinDe Zeng, YiMin Mao, et al. · Hepatology · 73

PDF

Hepatitis B: overview of the burden of disease in the Asia‐Pacific region

2006 · Laurentius A. Lesmana, Nancy Wai‐Yee Leung, et al. · Liver International · 67

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China

2008 · Guangbi Yao, Chengwei Chen, et al. · Hepatology International · 45

PDF

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China

2007 · Guangbi Yao, Chengwei Chen, et al. · Hepatology International · 41

PDF

Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China

2007 · Guangbi Yao · Journal of Antimicrobial Chemotherapy · 35

Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study

2008 · Guangbi Yao, ChengWei Chen, et al. · Hepatology International · 25

PDF

A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.

2004 · Guang-Bi Yao, Zhen-Yu Cui, et al. · PubMed · 20

Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China

2007 · Guangbi Yao, Xiaqiu Zhou, et al. · Hepatology International · 15

PDF

Treatment of chronic hepatitis B in China

2000 · Guang‐Bi Yao · Journal of Gastroenterology and Hepatology · 12

[Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients].

2009 · Guang-bi Yao, Hong Ren, et al. · PubMed · 11

A multicenter, randomized, controlled trial of interferon alfacon‐1 compared with α‐2a‐interferon in Chinese patients with chronic hepatitis C virus infection

2000 · Guang‐Bi Yao, Xi‐Xian Fu, et al. · Journal of Gastroenterology and Hepatology · 11

[A double-blind, double-dummy, randomized, controlled study of entecavir versus lamivudine for treatment of chronic hepatitis B].

2006 · Guang-bi Yao, Mei Zhu, et al. · PubMed · 10

[The long-term efficacy of lamivudine in chronic hepatitis B: interim analysis of 3-year's clinical course].

2003 · Guang-bi Yao, Bao-en Wang, et al. · PubMed · 8

[The clinical characteristics of primary biliary cirrhosis in China: a systematic review].

2009 · Er-li Gu, Guang-bi Yao · PubMed · 7

An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.

2002 · Guangbi Yao, Zhenyu Cui, et al. · PubMed · 5

[Treatment of chronic hepatitis C by bicyclum, a randomized double-blind placebo controlled trial].

2002 · Guangbi Yao, Yanyan Ji, et al. · PubMed · 5

[A study of the dosage and efficacy of entecavir for treating hepatitis B virus].

2005 · Guang-bi Yao, Ding-feng Zhang, et al. · PubMed · 4

[Stress on clinical research of primary biliary cirrhosis].

2002 · Guangbi Yao · PubMed · 2

Quantitative assessment of IgM antibodies towards an immunodominant B‐cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection

1995 · Guo‐Zhong Fei, Staffan P. E. Sylvan, et al. · Journal of Medical Virology · 2

[Standardize the prevention and management practice of hepatitis B: comment on the Chinese 2005 guideline for hepatitis B infection].

2006 · Guang-Bi Yao · PubMed · 1

[Durability of HBeAg seroconversion in lamivudine treatment of chronic hepatitis B patients].

2005 · Mei Zhu, Bei Xu, et al. · PubMed · 1

Improvement of liver histology after one year of Lamivudine therapy in patients with chronic hepatitis B

2003 · Ronghua Jin, Zhenwei Lang, et al. · Gastroenterology · 1

M1924 Three-Years of Continuous Treatment with Entecavir Results in High Proportions of Chinese Nucleoside-Naive Patients with Undetectable HBV DNA: Results from Studies ETV-023 and -050

2008 · Guang-Bi Yao, Dao-Zhen Xu, et al. · Gastroenterology

PDF

Works count: 32

Citation count: 1,334

H-index: 11

I10-index: 14